Rubberex secures shareholders' approval to buy Reszon Diagnostics for RM180mil

KUALA LUMPUR: Rubberex Corp (M) Bhd has obtained its shareholders' approval for the proposed acquisition of 100% equity interest in Reszon Diagnostics International Sdn Bhd for RM180mil.

Its shareholders also approved the proposed diversification into the healthcare business and proposed change of name to Hextar Healthcare Bhd.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Subscribe

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Subscribe

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only

Subscribe
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Rubberex , Reszon Diagnostics , Hextar Healthcare

   

Report it to us.

Next In Business News
Poised for real estate growth
Future of architecture: blending tradition with modern design
Must-have gadgets for rental properties
Ringgit likely to trade on softer note next week
Nasdaq dreams aside, LYC must first focus on profitability
VS Industry eyes RM150mil capex
Licensing, freedom of expression and nation-building
Asia Internet is no longer Cuscapi’s substantial shareholder
Russia’s rich shop away despite sanctions
Optimism abounds in new year

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.